WeVote
Log In

Bill

Bill

HR 158

AUDIT-340B PROGRAM

104th Regular Session Introduced by Carol Ammons and 22 co-sponsors

Illinois bill establishes state auditing mechanism for federal 340B drug discount program to ensure healthcare entities comply with requirements and direct savings to eligible patients.

Rule 19(b) / Re-referred to Rules Committee
0
WeVote Research Nonpartisan
Bill Summary · HR 158

Legislative bill overview

HR 158 proposes to establish an audit mechanism for Illinois's participation in the federal 340B drug pricing program, which allows qualified healthcare entities to purchase certain medications at discounted prices. The bill would create oversight to ensure these discounts are being used appropriately and in compliance with program requirements.

Why is this important

The 340B program distributes billions in drug discounts annually, but lacks comprehensive state-level oversight. Without auditing mechanisms, there's potential for misuse of discounts or misalignment between program intent (serving uninsured/underinsured patients) and actual practice. This audit would provide transparency on whether Illinois healthcare entities are maximizing patient benefit from these federal discounts.

Potential points of contention

  • Implementation costs: State audits require resources; unclear who bears the administrative burden and whether it increases healthcare entity compliance costs
  • Federal-state jurisdiction questions: The 340B program is federally regulated; some may argue state audits create redundant oversight or conflict with federal authority
  • Proprietary business concerns: Healthcare entities may resist disclosure of drug pricing data, citing competitive sensitivity or trade secrets

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.